We do have COVID-19 IgG/IgM Immunoassay rapid tests to fight the pandemic
0

Tu carrito está vacío

We're Not Retail, We're Revolutionary

octubre 29, 2016

We're Not Retail, We're Revolutionary

Recently, we had the distinct displeasure of engaging in a phone conversation with a foundation here in New England. Before the call, it was exciting to think a local philanthropic foundation might not only grasped our innovative business model, but may also want to support Maternova as we scale globally. After the call, we realized the need to clarify again, that innovations will not reach end users unless they have a champion and are marketed!

It may be my enthusiasm for what we do here, but I feel the compunction to put in writing the inevitable confusion that ensued and our dismay over being told ‘no’ after only a fifteen minute conversation.

The haze surrounding our business model needs to be lifted. Please allow me to break this down into the simplest terms, so that we can all move forward. Maternova, Inc. is a social enterprise that is a for profit entity. We bring products to market that may never be commercialized were it not for us. By participating in the product trials, marketing, and even the regulatory approvals, Maternova is the trusted ally of many innovators. This trust results in our obtaining a favorable price point, and in many cases exclusive territories.

Let me be very clear – Maternova is **NOT** making a profit on women and newborns in jeopardy. Additionally, our prices (please feel free to do some checking), are below retail from the manufacturer. Do we have to mark them up? Yes. Are they still more affordable through us and in customized bundles than anywhere else? Absolutely. Do we spend upwards of 100+ hours per product to properly register, package, and ship with all customs fees and brokers fees paid by Maternova? Yes.

So, there is your answer, we are not lining our pockets taking money from vulnerable and venerable caregivers. We operate on occasion at a loss to save women and children. Any statement to the contrary is untrue.

I hope this provides some much needed clarity. As we are surging ahead, we’ve also launched a non-profit entity, [Maternova Research](http://maternova.net/announcing-maternova-research-non-profit-affiliate-maternova). The difference between the two is the 501c3 is going to house the highly coveted Innovation Index, and allow us to build it out even more. It takes hundreds of hours to compile our database. In order to successfully improve an already renowned resource we NEED funding in the form of donations. The donations are tax deductible, and will be greatly appreciated.

I hope this lifts the veil on what we are, and why we are bothering to explain it here. We’re innovative and nimble and we are NOT retail – we’re revolutionary. Thank you!

a.e.cote 8/2013

Dejar un comentario

Los comentarios se aprobarán antes de mostrarse.


Ver artículo completo

High-Fidelity Lactation Simulators Hit the Market and Spur More Realistic Teaching on Breast Health and Lactation
High-Fidelity Lactation Simulators Hit the Market and Spur More Realistic Teaching on Breast Health and Lactation

enero 03, 2021

Maternova is proud to partner with LiquidGoldConcept, a women-founded team of experts, who have created a high-fidelity lactation simulator capable of modeling a wide variety of breastfeeding complications. The world’s first realistic  and wearable  breastfeeding training tool for parents, students and medical providers, LiquidGoldConcept’s lactation simulation models simulate a wide range of normal (and abnormal) conditions that include early stage mastitis, engorgement, plugged ducts, as well as nipple damages and fissures.
Ver artículo completo
2020 in Review: The State of Maternal and Neonatal Health
2020 in Review: The State of Maternal and Neonatal Health

noviembre 04, 2020

Assessing the global status of maternal and neonatal health in 2020 presents a varied, albeit alarming, view of the lives of mothers and newborns around the world. The socioeconomic strain of the COVID-19 pandemic, moreover, has caused upticks in adult and child malnutrition, leading experts to predict a rise in maternal and neonatal mortality this year. 

Ver artículo completo
New preeclampsia risk-factor checklists to aid health care providers in identifying pregnant women who may benefit from prophylactic low-dose aspirin
New preeclampsia risk-factor checklists to aid health care providers in identifying pregnant women who may benefit from prophylactic low-dose aspirin

agosto 14, 2020

This past June, the Society for Maternal-Fetal Medicine (SMFM) published in the   American Journal of Obstetrics and Gynecology   a special statement on a collection of two new checklists they created to support health care providers in identifying pregnant women at heightened risk of developing preeclampsia, a major cause of maternal and perinatal morbidity and mortality. 
Ver artículo completo
Noticias y actualizaciones

Regístrate gratis para obtener lo último en ventas, nuevos lanzamientos y más…

maternal and newborn health news